6-heptyne-2,5-diamine has been researched along with Leukemia P388 in 2 studies
*Leukemia P388: An experimental lymphocytic leukemia originally induced in DBA/2 mice by painting with methylcholanthrene. [MeSH]
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bartholeyns, J; Casara, P; Mamont, P | 1 |
| Bencsik, K; Boldizsár, M; Kálnay, A; Kremmer, T; Mihalik, R; Pályi, I; Turi, G | 1 |
2 other study(ies) available for 6-heptyne-2,5-diamine and Leukemia P388
| Article | Year |
|---|---|
Antitumor properties of (2R,5R)-6-heptyne-2,5-diamine, a new potent enzyme-activated irreversible inhibitor of ornithine decarboxylase, in rodents.
Topics: Alkynes; Animals; Antineoplastic Agents; Diamines; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Eflornithine; Female; Leukemia L1210; Leukemia P388; Liver Neoplasms, Experimental; Lung Neoplasms; Mammary Neoplasms, Experimental; Mice; Mice, Inbred Strains; Neoplasms, Experimental; Ornithine; Ornithine Decarboxylase Inhibitors; Rats; Rats, Inbred BUF | 1984 |
Effects of methylacetylenic putrescine, an ornithine decarboxylase inhibitor and potential novel anticancer agent, on human and mouse cancer cell lines.
Topics: Alkynes; Animals; Antineoplastic Agents; Breast Neoplasms; Cell Cycle; Cell Death; Cell Division; Cell Survival; Diamines; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Female; Humans; Inhibitory Concentration 50; Leukemia P388; Male; Mice; Ornithine Decarboxylase; Ornithine Decarboxylase Inhibitors; Polyamines; Prostatic Neoplasms; Thyroid Neoplasms; Tumor Cells, Cultured | 1999 |